Using albumin bilirubin index to predict outcomes of variceal bleeding
Albumin Bilirubin Index as a Predictor of Outcome of Variceal Bleeding
This study tests if a special index can help predict the chances of repeated bleeding in patients with cirrhosis after they receive treatment for esophageal varices.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 48 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Assiut University Academic / other |
| Locations | 1 site (Asyut) |
| Trial ID | NCT06614114 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the predictive value of the albumin bilirubin index in forecasting recurrent variceal bleeding within three months following endoscopic treatment in patients diagnosed with cirrhosis and esophageal variceal gastrointestinal bleeding (EGVB). By analyzing patient data, the study seeks to identify how effectively this index can indicate potential complications and guide clinical decisions. The methodology involves monitoring patients who meet specific inclusion criteria and assessing their outcomes post-treatment.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 to 80 years with a diagnosis of cirrhosis and a history of esophageal variceal bleeding.
Not a fit: Patients with hematological diseases or hepatocellular carcinoma (HCC) may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could help clinicians better predict and manage the risk of recurrent variceal bleeding in patients with cirrhosis.
How similar studies have performed: While the predictive value of various indices has been explored in similar contexts, this specific approach using the albumin bilirubin index is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * age between 18-80 years old Exclusion Criteria: * Hcc Hematological disease
Where this trial is running
Asyut
- Assiut university hospital — Asyut, Egypt (Recruiting)
Study contacts
- Principal investigator: Heba Sayed Zaki — Assiut University
- Study coordinator: Heba Sayed Zaki
- Email: hoopa.1996@gmail.com
- Phone: 0201148259100
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.